These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16601646)

  • 1. Stimulant treatment over 5 years: effects on growth.
    Charach A; Figueroa M; Chen S; Ickowicz A; Schachar R
    J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV; Biederman J; Morley CP; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P; Maipang P
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
    Zhang H; Du M; Zhuang S
    Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
    Charach A; Ickowicz A; Schachar R
    J Am Acad Child Adolesc Psychiatry; 2004 May; 43(5):559-67. PubMed ID: 15100562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term psychostimulant medication on growth of children with ADHD.
    Zachor DA; Roberts AW; Hodgens JB; Isaacs JS; Merrick J
    Res Dev Disabil; 2006; 27(2):162-74. PubMed ID: 15955659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Jacobsen SJ
    J Dev Behav Pediatr; 2007 Aug; 28(4):274-87. PubMed ID: 17700079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review.
    Kim HW; Kim SO; Shon S; Lee JS; Lee HJ; Choi JH
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):448-53. PubMed ID: 25285915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.
    Chacko A; Pelham WE; Gnagy EM; Greiner A; Vallano G; Bukstein O; Rancurello M
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
    Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
    Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder.
    Spencer TJ; Newcorn JH; Kratochvil CJ; Ruff D; Michelson D; Biederman J
    Pediatrics; 2005 Jul; 116(1):e74-80. PubMed ID: 15995021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth on stimulant medication; clarifying the confusion: a review.
    Poulton A
    Arch Dis Child; 2005 Aug; 90(8):801-6. PubMed ID: 16040876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches.
    Hanć T; Cieślik J
    Pediatrics; 2008 Apr; 121(4):e967-74. PubMed ID: 18381524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.
    Thiruchelvam D; Charach A; Schachar RJ
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):922-8. PubMed ID: 11501692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
    Spencer TJ; Biederman J; Harding M; O'Donnell D; Faraone SV; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nutrition and attention deficit hyperactivity disorder: developmental follow-up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled-release methylphenidate].
    Dura-Trave T; Yoldi-Petri ME; Zardoya-Santos P
    Rev Neurol; 2011 Sep; 53(5):257-64. PubMed ID: 21796603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.